Endocrine Complications of Anorexia Nervosa

Overview

Journal J Eat Disord

Publisher Biomed Central

Date 2023 Feb 16

PMID 36793059

Authors

Melanie S Haines

Affiliations

Soon will be listed here.

Abstract

An important component in the treatment of anorexia nervosa (AN) is the evaluation and management of its endocrine complications, including functional hypogonadotropic hypogonadism and increased fracture risk. The body's adaptive response to chronic starvation results in many endocrine abnormalities, most of which are reversible upon weight restoration. A multidisciplinary team with experience in treating patients with AN is critical to improving endocrine outcomes in patients with this disorder, including in women with AN who are interested in fertility. Much less is understood about endocrine abnormalities in men, as well as sexual and gender minorities, with AN. In this article, we review the pathophysiology and evidence-based recommendations for the treatment of endocrine complications in AN, as well as discuss the status of clinical research in this area.

Citing Articles

Patterns of Medical Diagnoses Before and After a Diagnosis of Anorexia Nervosa: A Danish Nationwide Cohort Study.

Soeby M, Clausen L, Richelsen B, Gribsholt S Int J Eat Disord. 2025; 58(3):624-634.

PMID: 39763082 PMC: 11891635. DOI: 10.1002/eat.24340.

Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.

Koning E, Chaves C, Kirkpatrick R, Brietzke E J Eat Disord. 2024; 12(1):214.

PMID: 39731144 PMC: 11673730. DOI: 10.1186/s40337-024-01185-8.

Assessment of the renal function of patients with anorexia nervosa.

Miyahara H, Shigeyasu Y, Fujii C, Tanaka C, Hanzawa M, Sugihara A Biopsychosoc Med. 2024; 18(1):19.

PMID: 39343908 PMC: 11439319. DOI: 10.1186/s13030-024-00316-6.

Ovarian hormones and eating disorders.

Young J Front Psychol. 2024; 15:1467795.

PMID: 39315050 PMC: 11416966. DOI: 10.3389/fpsyg.2024.1467795.

Medical Considerations and Consequences of Eating Disorders.

Carlson J, Lemly D Focus (Am Psychiatr Publ). 2024; 22(3):301-306.

PMID: 38988462 PMC: 11231475. DOI: 10.1176/appi.focus.20230042.

References

Schorr M, Thomas J, Eddy K, Dichtel L, Lawson E, Meenaghan E . Bone density, body composition, and psychopathology of anorexia nervosa spectrum disorders in DSM-IV vs DSM-5. Int J Eat Disord. 2016; 50(4):343-351. PMC: 5313383. DOI: 10.1002/eat.22603. View

Oskis A, Loveday C, Hucklebridge F, Thorn L, Clow A . Diurnal patterns of salivary cortisol and DHEA in adolescent anorexia nervosa. Stress. 2012; 15(6):601-7. DOI: 10.3109/10253890.2012.661493. View

Miller K, Grinspoon S, Ciampa J, Hier J, Herzog D, Klibanski A . Medical findings in outpatients with anorexia nervosa. Arch Intern Med. 2005; 165(5):561-6. DOI: 10.1001/archinte.165.5.561. View

Karczewska-Kupczewska M, Straczkowski M, Adamska A, Nikolajuk A, Otziomek E, Gorska M . Increased suppression of serum ghrelin concentration by hyperinsulinemia in women with anorexia nervosa. Eur J Endocrinol. 2009; 162(2):235-9. DOI: 10.1530/EJE-09-0832. View

Lawson E, Misra M, Meenaghan E, Rosenblum L, Donoho D, Herzog D . Adrenal glucocorticoid and androgen precursor dissociation in anorexia nervosa. J Clin Endocrinol Metab. 2009; 94(4):1367-71. PMC: 2682472. DOI: 10.1210/jc.2008-2558. View

Misra M, Katzman D, Estella N, Eddy K, Weigel T, Goldstein M . Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial. J Clin Psychiatry. 2013; 74(8):e765-71. PMC: 4017248. DOI: 10.4088/JCP.13m08365. View

Fazeli P, Misra M, Goldstein M, Miller K, Klibanski A . Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. J Clin Endocrinol Metab. 2009; 95(1):369-74. PMC: 2805486. DOI: 10.1210/jc.2009-1730. View

Misra M, Tsai P, Anderson E, Hubbard J, Gallagher K, Soyka L . Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am J Clin Nutr. 2006; 84(4):698-706. PMC: 3210565. DOI: 10.1093/ajcn/84.4.698. View

Becker K, Mancuso C, Dreier M, Asanza E, Breithaupt L, Slattery M . Ghrelin and PYY in low-weight females with avoidant/restrictive food intake disorder compared to anorexia nervosa and healthy controls. Psychoneuroendocrinology. 2021; 129:105243. PMC: 8363304. DOI: 10.1016/j.psyneuen.2021.105243. View

10.

Misra M, Prabhakaran R, Miller K, Tsai P, Lin A, Lee N . Role of cortisol in menstrual recovery in adolescent girls with anorexia nervosa. Pediatr Res. 2006; 59(4 Pt 1):598-603. DOI: 10.1203/01.pdr.0000203097.64918.63. View

11.

Xie T, Leung P . Fibroblast growth factor 21: a regulator of metabolic disease and health span. Am J Physiol Endocrinol Metab. 2017; 313(3):E292-E302. PMC: 5625087. DOI: 10.1152/ajpendo.00101.2017. View

12.

Nagata J, Golden N, Peebles R, Long J, Murray S, Leonard M . Assessment of Sex Differences in Body Composition Among Adolescents With Anorexia Nervosa. J Adolesc Health. 2017; 60(4):455-459. PMC: 6402565. DOI: 10.1016/j.jadohealth.2016.11.005. View

13.

Galbally M, Himmerich H, Senaratne S, Fitzgerald P, Frost J, Woods N . Management of anorexia nervosa in pregnancy: a systematic and state-of-the-art review. Lancet Psychiatry. 2022; 9(5):402-412. DOI: 10.1016/S2215-0366(22)00031-1. View

14.

Golden N, Iglesias E, Jacobson M, Carey D, Meyer W, Schebendach J . Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2005; 90(6):3179-85. DOI: 10.1210/jc.2004-1659. View

15.

Tam F, Seidel M, Boehm I, Ritschel F, Bahnsen K, Biemann R . Peptide YY concentration in acute- and long-term recovered anorexia nervosa. Eur J Nutr. 2020; 59(8):3791-3799. PMC: 7669786. DOI: 10.1007/s00394-020-02210-7. View

16.

Putignano P, Dubini A, Toja P, Invitti C, Bonfanti S, Redaelli G . Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol. Eur J Endocrinol. 2001; 145(2):165-71. DOI: 10.1530/eje.0.1450165. View

17.

Stoving R, Veldhuis J, Flyvbjerg A, Vinten J, Hangaard J, Koldkjaer O . Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis. J Clin Endocrinol Metab. 1999; 84(6):2056-63. DOI: 10.1210/jcem.84.6.5734. View

18.

Fazeli P, Bredella M, Misra M, Meenaghan E, Rosen C, Clemmons D . Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa. J Clin Endocrinol Metab. 2009; 95(1):407-13. PMC: 2805488. DOI: 10.1210/jc.2009-1152. View

19.

Demitrack M, Lesem M, Listwak S, BRANDT H, Jimerson D, Gold P . CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations. Am J Psychiatry. 1990; 147(7):882-6. DOI: 10.1176/ajp.147.7.882. View

20.

Leddy M, Jones C, Morgan M, Schulkin J . Eating disorders and obstetric-gynecologic care. J Womens Health (Larchmt). 2009; 18(9):1395-401. DOI: 10.1089/jwh.2008.1183. View